Drug-coated stents cut repeat blockages in leg artery procedures

Swedish trial data shows paclitaxel-coated devices significantly reduce the need for repeat interventions in peripheral artery disease patients. The finding could reshape treatment protocols and reduce healthcare costs for a condition affecting millions globally.

Originaltitel: Target Vessel Binary Re-stenosis following the Use of Paclitaxel Coated Versus Uncoated Devices during Infrainguinal Endovascular Revascularisation of Symptomatic Peripheral Arterial Disease: Exploratory Data from the SWEDEPAD 1 and 2 Trials